Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: a multicenter study.

Ruiz PJ, García; Ignacio A, Sesar; Pensado B, Ares; García A, Castro; Frech F, Alonso; López M, Alvarez; González J, Arbelo; Octavio J, Baiges; Hernández JA, Burguera; Garriga M, Calopa; Blanco D, Campos; García B, Castaño; Cordero M, Carballo; Peña J, Chacón; Ibáñez A, Espino; Onisalde A, Gorospe; S, Giménez-Roldán; Ibáñez P, Granés; Vara J, Hernández; Alonso R, Ibáñez; Jiménez FJ, Jiménez; J, Krupinski; Bojarsky J, Kulisevsky; Ramírez I, Legarda; García E, Lezcano; JC, Martínez-Castrillo; González D, Mateo; Rodríguez F, Miquel; P, Mir; Fargas E, Muñoz; Inchausti J, Obeso; Romero J, Olivares; Plana J, Olivé; Vallejo P, Otermin; Sedano B, Pascual; de Colosía Rama V, Pérez; López-Fraile I, Pérez; Comes A, Planas; Periz V, Puente; Oroz MC, Rodríguez; García D, Sevillano; Pérez P, Solís; Muñoz J, Suárez; Gamo J, Vaamonde; Merino C, Valero; Serra F, Valldeoriola; Pérez JM, Velázquez; Baña R, Yáñez; Capdepon I, Zamarbide

doi:10.1002/mds.22063

Public

Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: a multicenter study.

Shared by NobleBlocks on Jun 1, 2008 • 12:00 AM UTC

Authors:

García Ruiz PJ

Sesar Ignacio A

Ares Pensado B

Abstract

Continuous subcutaneous apomorphine infusion (CSAI) is, at present, an alternative option for advanced Parkinson's disease (PD) with motor fluctuations. We studied the evolution of patients with PD and severe motor fluctuations long-term treated with CSAI. We reviewed data from 82 patients with PD (...

Discussions